Clinical Trial: Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmi

Brief Summary: Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)

Detailed Summary:
Sponsor: Santen Inc.

Current Primary Outcome: Concentration of levofloxacin and moxifloxacin in the corneal tissue [ Time Frame: Time of surgery ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Adverse Events [ Time Frame: 4 days ]

Original Secondary Outcome: Same as current

Information By: Santen Inc.

Dates:
Date Received: September 26, 2008
Date Started: September 2008
Date Completion:
Last Updated: August 24, 2009
Last Verified: August 2009